Myriad Genetics, Inc. Hires JPMorgan to Explore Splitting Business

August 20, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Aug. 19 (Bloomberg) -- Myriad Genetics Inc. hired the investment bank JPMorgan Chase & Co. to explore separating Myriad's drug-development and genetic-testing businesses after its experimental treatment for Alzheimer's disease failed.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions People